Search for a clinical trial
Other search option(s)
6 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Terminated trial = 
; Funded by an IRDiRC member = 
; Study involving ERN members in at least two Member States = 
National clinical trial(s)
BELGIUM
ANTWERPEN
EDEGEM (ANTWERPEN)
Efficacy and Safety of a 4 Year Combination Therapy of Growth Hormone and Gonadotropin- Releasing Hormone Agonist in Children With a Short Predicted Height
Antwerp University Hospital - UZA
Kindergeneeskunde/Pediatrics
FRANCE
HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR
A Randomised, Open-labelled, Active-controlled, Multinational, Dose-escalation Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (NNC0195-0092) Compared to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency (Phase I) - FR
Institution: Information not provided - FR
FRANCE
ILE-DE-FRANCE
PARIS
Randomised cross-over double blind versus placebo trial followed by an open phase studying effect of Norditropin on left ventricular mass of growth hormone deficient adult patients (Phase IV) - Terminated -
AP-HP.Sorbonne Université - Hôpital Saint-Antoine
Service d'Endocrinologie, Diabétologie et Médecine de la reproduction
GERMANY
Baden-Württemberg
FREIBURG
Can treatment with human growth hormone increase strength in spinal muscular atrophy type II and III (phase II study)?
Zentrum für Kinder- und Jugendmedizin Freiburg
Klinik für Neuropädiatrie und Muskelerkrankungen
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
A Randomised, Open-labelled, Active-controlled, Multinational, Dose-escalation Trial Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Dose of Long-acting Growth Hormone (NNC0195-0092) [...] to Daily Dosing of Norditropin® SimpleXx® in Children With Growth Hormone Deficiency - ES (completed)
Hospital Sant Joan de Déu Barcelona
Servicio de Endocrinología
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES